search
Back to results

Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus

Primary Purpose

Sleep Disturbances, Tinnitus

Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
The gel contains a mixture of glucose and maltodextrin
Herbal compound low-dose
Herbal compound high-dose
Sponsored by
Dalin Tzu Chi General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Sleep Disturbances

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age 20~70 years old
  2. Non-dialysis patients
  3. Suffering from sleep disorders and tinnitus
  4. Refuse to take sleeping pills

Exclusion criteria:

  1. Patients who are bedridden or unable to take care of themselves.
  2. dialysis patients.
  3. Patients who cannot understand the details of this study or cannot cooperate with the examination.
  4. History of alcohol or drug abuse.
  5. Pregnant and lactating women
  6. Patients with moderate to severe sleep apnea
  7. Take sleeping pills

Sites / Locations

  • Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Placebo Comparator

Experimental

Experimental

Arm Label

Control

Herbal compound low-dose

Herbal compound high-dose

Arm Description

receive placebo treatment, once a day, four pills each time.

once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg.

once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg.

Outcomes

Primary Outcome Measures

Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each aspect has a minimum score of 0 and a maximum of 3 points. The total score range is 0-21 points. When the PSQI score is greater than 5 points, it indicates that there is a sleep quality disorder. The higher the score, the worse the sleep quality.
Tinnitus Handicap Inventory
The Tinnitus Handicap Inventory (THI) comprises 25 items grouped into three subscales: Functional, Emotional, and Catastrophic. The Functional subscale (11 items) deals with limitations caused by tinnitus in the areas of mental, social, and physical functioning. The Emotional subscale (9 items) concerns affective responses to tinnitus, e.g. anger, frustration, depression, anxiety. The Catastrophic subscale (5 items) probes the most severe reactions to tinnitus, such as loss of control, inability to escape from tinnitus, and fear of having a terrible disease. For each item a patient can respond with a "yes" (scored 4 points), "sometimes" (2 points), or "no" (0 points). The responses are summed within each subscale and for the total scale. The higher the score, the greater the perceived tinnitus severity.

Secondary Outcome Measures

Full Information

First Posted
August 27, 2021
Last Updated
August 31, 2023
Sponsor
Dalin Tzu Chi General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05212298
Brief Title
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus
Official Title
Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus: Prospective, Randomized, Double-blinded Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 16, 2021 (Actual)
Primary Completion Date
September 30, 2024 (Anticipated)
Study Completion Date
January 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Dalin Tzu Chi General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method. 120 adults were divided into 3 groups. Control group: receive placebo treatment, once a day, four pills each time. Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg. Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg. All subjects received health questionnaire, sleep questionnaire and tinnitus questionnaire before the start of the test At the end of the treatment(3 months), the health questionnaire, sleep questionnaire, and tinnitus questionnaire were accepted.
Detailed Description
Sleep disturbances were very popular in general population. The prevalence of sleep disturbances were about 20 ~30% in adults. Insomnia is a complex disease with many etiologies. For example, pressure from daily activity, psychiatric diseases, and organic diseases may contribute to sleep disturbances. Besides, insomnia often comorbid comorbidly with tinnitus, and form a vicious cycle between insomnia and tinnitus. In the aspect of treatment, besides psychological treatment, insomnia was often treated with hypnotics. Variable types of GABA agonists and/or antidepression agents, including selective serotonin reuptake inhibitor (SSRI) were often used for insomnia. However, the medical treatments for insomnia patients were unsatisfactory, and many patients search for traditional Chinese medicine and/or herbal medicine. Tinnitus can be defined as a phantom auditory perception in the absence of an external sound source. It is a common auditory symptom with a prevalence ranges from 4.6% in a survey study in Iranian population to 25.3% in a nationally representative survey in the United States, depending on the definition of tinnitus and study populations. A recent nationwide survey of the general population of South Korea reported that the prevalence of any tinnitus was 20.7% among adults aged 20 to 98 years. The prevalence was higher in women and it increased with age. A cohort study in England indicated that the incidence of clinically significant tinnitus was 5.4 cases per 10,000 person-years. Tinnitus can severely interfere with activities of daily living, with common comorbidities such as anxiety, irritability, depression, inability to concentration, and sleep disturbances. Studies based on both questionnaires and polysomnography reported that sleep disturbance are common in patients with tinnitus. Recently, the investigators found that the risk of tinnitus was increased in middle-aged and elderly patients with sleep disturbance and/or sleep apnea. In the aspect of treatment, GABA agonists were often used to for tinnitus, but the results are still unsatisfactory till now. Since many years ago, traditional Chinese medicine or herbal medicine had take care of insomnia and tinnitus. Some herbal foods and/or drugs, for example Lemon Balm Extract、Rice bran fermentation extract (GABA)、L-Tryptophan, were suggested for these two diseases with various results. In this study ,the investigators aimed to investigate the effects of herbal sleep formula on the sleep and tinnitus of patients without hemodialysis or peritoneal dialysis. This project is planned to collect non-dialysis adults who suffer from sleep and tinnitus disorders and refuse to take sleeping medicines in our hospital by random assignment and double-blind method. 120 adults were divided into 3 groups. Control group: receive placebo treatment, once a day, four pills each time. Herbal compound low-dose group: once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg. Herbal compound high-dose group: once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg. All subjects received health questionnaire, sleep questionnaire and tinnitus questionnaire before the start of the test At the end of the treatment(3 months), the health questionnaire, sleep questionnaire, and tinnitus questionnaire were accepted.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disturbances, Tinnitus

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
receive placebo treatment, once a day, four pills each time.
Arm Title
Herbal compound low-dose
Arm Type
Experimental
Arm Description
once a day, two herbal compound capsules and two placebos each time. The total amount of herbal compound capsules is 557 mg.
Arm Title
Herbal compound high-dose
Arm Type
Experimental
Arm Description
once a day, four capsules each time. The total amount of herbal compound capsules is 1114 mg.
Intervention Type
Dietary Supplement
Intervention Name(s)
The gel contains a mixture of glucose and maltodextrin
Intervention Description
The gel contains a mixture of glucose and maltodextrin - a complex carbohydrate - along with fat and a trace of protein.
Intervention Type
Dietary Supplement
Intervention Name(s)
Herbal compound low-dose
Intervention Description
The total amount of herbal compound capsules is 557 mg.
Intervention Type
Dietary Supplement
Intervention Name(s)
Herbal compound high-dose
Intervention Description
The total amount of herbal compound capsules is 1114 mg.
Primary Outcome Measure Information:
Title
Pittsburgh Sleep Quality Index
Description
The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. Nineteen individual items generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Each aspect has a minimum score of 0 and a maximum of 3 points. The total score range is 0-21 points. When the PSQI score is greater than 5 points, it indicates that there is a sleep quality disorder. The higher the score, the worse the sleep quality.
Time Frame
3 month
Title
Tinnitus Handicap Inventory
Description
The Tinnitus Handicap Inventory (THI) comprises 25 items grouped into three subscales: Functional, Emotional, and Catastrophic. The Functional subscale (11 items) deals with limitations caused by tinnitus in the areas of mental, social, and physical functioning. The Emotional subscale (9 items) concerns affective responses to tinnitus, e.g. anger, frustration, depression, anxiety. The Catastrophic subscale (5 items) probes the most severe reactions to tinnitus, such as loss of control, inability to escape from tinnitus, and fear of having a terrible disease. For each item a patient can respond with a "yes" (scored 4 points), "sometimes" (2 points), or "no" (0 points). The responses are summed within each subscale and for the total scale. The higher the score, the greater the perceived tinnitus severity.
Time Frame
3 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 20~70 years old Non-dialysis patients Suffering from sleep disorders and tinnitus Refuse to take sleeping pills Exclusion criteria: Patients who are bedridden or unable to take care of themselves. dialysis patients. Patients who cannot understand the details of this study or cannot cooperate with the examination. History of alcohol or drug abuse. Pregnant and lactating women Patients with moderate to severe sleep apnea Take sleeping pills
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Juen-Haur Hwang, MD, PhD.
Phone
+886-5-2648000
Ext
5329
Email
g120796@tzuchi.com.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juen-Haur Hwang, MD, PhD.
Organizational Affiliation
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Official's Role
Study Chair
Facility Information:
Facility Name
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
City
Chiayi City
ZIP/Postal Code
66247
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juen-Haur Hwang, MD, PhD
Phone
+886-5-2648000
Ext
5239
Email
g120796@tzuchi.com.tw

12. IPD Sharing Statement

Learn more about this trial

Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus

We'll reach out to this number within 24 hrs